Skip to content Skip to contact
Global Vox Populi

Biotech market research agency in Turkey

Seeking Biotech Market Insights in Turkey?

Turkey’s biotech sector is seeing significant investment, driven by both domestic innovation and global pharmaceutical interest. Companies operating here need granular data on market access, regulatory shifts, and physician prescribing patterns.

Understanding the local healthcare network requires deep, specialized research capabilities. Global Vox Populi provides biotech market research in Turkey, helping organizations manage these specific challenges. We deliver the insights needed for strategic decision-making in this evolving market.

What we research in Turkey

In Turkey, our biotech market research projects address critical questions across the pharmaceutical and life sciences spectrum. We conduct brand health studies for new drug launches and existing portfolios.

Segmentation research helps identify distinct patient and physician groups. We also map treatment journeys, from diagnosis through therapy selection and adherence. Concept testing for medical devices or new therapeutic areas is common.

Our work includes market access studies, competitive intelligence, and opportunity sizing for novel biotechnologies. Each brief is unique, and we customize our research scope to specific client objectives.

Why Biotech market research fits (or struggles) in Turkey

Biotech market research in Turkey benefits from a relatively concentrated healthcare professional (HCP) community in major urban centers.

This often makes targeted recruitment for specialists like oncologists or neurologists more feasible. However, reaching specific patient cohorts, especially those with rare diseases, presents a challenge due to privacy regulations and fragmented patient registries.

Our methods are designed to reach key opinion leaders and practicing physicians effectively. While Turkish is the dominant language, urban areas, particularly Istanbul and Ankara, often have HCPs comfortable with English.

Recruitment for highly niche B2B segments, such as R&D directors in smaller biotech firms, can be demanding. We sometimes recommend combining qualitative depth with quantitative screening to deliver representativeness in these instances.

How we run Biotech market research in Turkey

Recruitment for biotech studies in Turkey often draws from specialized in-country HCP panels and professional databases.

For hard-to-reach or very specific profiles, we employ targeted outreach through medical associations or patient advocacy groups. Our screening process includes multiple validators and attention checks to deliver respondent authenticity and adherence to criteria.

Recent-participation flags prevent over-recruitment from specific panels. Fieldwork formats vary, from online qualitative platforms for in-depth interviews in Turkey with physicians to in-person focus groups in Istanbul or Ankara. All fieldwork is conducted in Turkish.

Our moderators and interviewers are typically senior researchers with a background in healthcare or pharmaceuticals, fluent in Turkish, and trained in medical terminology. Quality assurance runs throughout fieldwork, including daily checks on recruitment quotas and respondent engagement.

Deliverables include full transcripts, thematic analysis reports, and debrief decks with strategic implications. Project management maintains a consistent cadence, with regular updates from a single project lead. If you would like to tell us about your project, we are ready to listen.

We also conduct biotech market research in Greece for regional studies.

Where we field in Turkey

Our biotech market research fieldwork in Turkey concentrates primarily on the major metropolitan areas.

This includes Istanbul, Ankara, and Izmir, which host significant pharmaceutical companies, medical centers, and a high concentration of healthcare professionals. Beyond these hubs, we extend our reach to cities like Bursa, Antalya, and Adana, using a network of local partners and online methodologies.

For specific projects requiring insights from more rural or less urbanized regions, we adapt our approach, often employing remote interview techniques or local intercepts where feasible. All research, regardless of location, is conducted with native Turkish speakers.

This makes sure cultural nuance is captured and understood.

Methodology, standards, and ethics

We operate under strict ethical guidelines, aligning with ESOMAR principles and the ICC/ESOMAR International Code on Market, Opinion and Social Research and Data Analytics (2016 revision).

Where applicable, we adhere to ISO 20252:2019 standards for market, opinion, and social research. Our work in Turkey also considers the guidelines of TUAD, the Turkish Researchers’ Association.

For qualitative biotech research, we employ semi-structured guides and laddering techniques for IDIs, while quantitative studies follow AAPOR response rate definitions for data collection methods like CAWI.

These standards are applied rigorously to biotech research. Respondent consent forms clearly outline data usage, anonymization protocols, and the right to withdraw.

We guarantee all participants, particularly healthcare professionals, understand the research objectives and that their responses will be aggregated and anonymized. Disclosures to respondents specify the purpose of the research and confirm no personal identifying information will be shared with third parties.

Quality assurance is integral to every project. This includes peer review of research instruments and analysis. For quantitative data, we run back-checks and quota validations to confirm sample integrity. Qualitative transcripts undergo coding and thematic analysis by experienced researchers.

Statistical validation is applied to quantitative datasets, delivering data accuracy and reliability before final delivery.

Drivers and barriers for Biotech market research in Turkey

DRIVERS:

  • Turkey’s strong domestic pharmaceutical manufacturing base and increasing R&D investment drive demand for biotech market intelligence.
  • The growing prevalence of chronic diseases and an aging population also necessitate new therapeutic solutions, fueling research into market needs.
  • High digital adoption rates among younger HCPs support online research methodologies.
  • A willingness among Turkish professionals to participate in well-structured research studies further supports fieldwork.

BARRIERS:

  • Regulatory friction, particularly around patient data access, can complicate certain types of biotech research.
  • Cultural sensitivity in discussing specific health conditions or treatment choices requires skilled moderation.
  • Reaching very niche B2B audiences, such as specialized researchers in smaller biotech startups, can be challenging due to limited public databases.
  • Language fragmentation, although less pronounced in the primary medical community, still requires careful handling for broader patient populations.

Compliance and data handling under Turkey’s framework

In Turkey, we strictly comply with the Personal Data Protection Law (KVKK), Law No. 6698. This framework governs the processing of personal data, including health-related information, which is central to biotech market research.

Our processes deliver explicit consent capture from all participants, especially for sensitive data categories. Data residency requirements are met through secure local servers or ESOMAR-aligned global protocols that respect KVKK.

Anonymization and pseudonymization techniques are applied diligently to all collected data. Respondents retain clear rights to access, rectify, or withdraw their data, which we fully respect and support throughout the research lifecycle.

Top 20 industries we serve in Turkey

  • Biotechnology & Pharma: HCP segmentation, treatment journey mapping, market access studies for new compounds.
  • Medical Devices: Product concept testing, surgeon and patient experience research, competitive assessments.
  • Healthcare Providers: Patient satisfaction, hospital choice drivers, service line development.
  • FMCG & CPG: Consumer usage and attitudes, brand perception, new product development research.
  • Banking & Financial Services: Customer experience tracking, digital banking adoption, product concept testing.
  • Automotive & Mobility: Brand health, EV intent, post-purchase satisfaction among Turkish consumers.
  • Retail & E-commerce: Shopper journey research, online conversion analysis, store experience studies.
  • Technology & SaaS: Product-market fit research, user experience studies, feature prioritization.
  • Telecom: Plan satisfaction, churn drivers, 5G adoption among Turkish subscribers.
  • Food & Beverage: Menu testing, consumption habits, brand perception for local and international brands.
  • Tourism & Hospitality: Booking journey research, loyalty program studies, destination perception.
  • Energy & Utilities: Customer satisfaction, sustainability perception, service usage.
  • Real Estate & Construction: Buyer journey research, location preference studies, property investment insights.
  • Education: Course satisfaction, channel preference, student and parent decision-making.
  • Chemicals: B2B customer satisfaction, new material demand, supply chain insights.
  • Textiles & Apparel: Brand perception, channel mix, consumer preferences in fashion.
  • Logistics & Supply Chain: B2B shipper research, last-mile satisfaction, freight forwarder needs.
  • Agriculture: Farmer needs assessments, crop protection product research, market trends.
  • Media & Entertainment: Content testing, audience segmentation, subscription research for digital platforms.
  • Government & Public Sector: Citizen satisfaction with public services, policy research, opinion polling.

Learn more about our broader capabilities as market research companies in Turkey.

Companies and brands in our research universe in Turkey

Research projects we field in Turkey regularly cover the competitive sets of category leaders such as:

  • Abdi İbrahim
  • Eczacıbaşı İlaç Pazarlama
  • Bilim İlaç
  • Sanofi Turkey
  • Pfizer Turkey
  • Novartis Turkey
  • Roche Turkey
  • Bayer Turkey
  • Arçelik
  • Vestel
  • Turkcell
  • Vodafone Turkey
  • Garanti BBVA
  • Akbank
  • Migros
  • CarrefourSA
  • Turkish Airlines
  • Pegasus Airlines
  • Getir
  • Trendyol

Why teams choose Global Vox Populi as their Biotech market research agency in Turkey

Translation and back-translation for medical documents and qualitative outputs are handled in-house by native Turkish speakers with scientific backgrounds.

  1. Clients benefit from a single project lead who manages the study from kickoff through debrief, delivering continuity.
  2. We provide coded qualitative outputs while fieldwork is still in market, allowing for faster internal alignment and decision-making.
  3. Our adherence to global and local data privacy standards offers peace of mind.

Frequently Asked Questions

Q: What kinds of clients commission biotech market research in Turkey?

A: We work with multinational pharmaceutical companies, local biotech startups, medical device manufacturers, and healthcare investment firms. They seek insights on market entry, product launch strategies, competitive environments, and physician or patient perceptions. Our work supports decision-making for R&D, marketing, and market access teams operating in the Turkish healthcare sector.

Q: How do you deliver sample quality for Turkey’s diverse population?

A: We deliver sample quality through rigorous screening questionnaires and validation checks. For diverse populations in Turkey, we apply demographic quotas based on census data or client specifications. Our in-country partners have established panels and recruitment methods designed to reach varied socio-economic and geographic segments, maintaining representativeness.

Q: Which languages do you cover in Turkey?

A: Our primary language coverage in Turkey is Turkish. All fieldwork, interviews, and survey instruments are conducted and developed in native Turkish. For clients requiring materials in English, we provide professional translation and back-translation services performed by linguists with market research experience, particularly in healthcare contexts.

Q: How do you reach hard-to-find audiences (senior B2B, low-incidence consumer segments) in Turkey?

A: Reaching hard-to-find audiences in Turkey involves multiple strategies. For senior B2B professionals, we use proprietary databases, professional networking, and referrals. Low-incidence consumer segments often require targeted screening questions within larger panels or collaboration with patient advocacy groups, always adhering to ethical guidelines.

Q: What is your approach to data privacy compliance under Turkey’s framework?

A: We comply fully with Turkey’s KVKK for all data handling. This means obtaining explicit consent, implementing reliable anonymization, and making sure data is processed and stored securely. Respondents are informed of their rights, including data access and deletion, and we support these requests promptly.

Q: How do you manage cultural sensitivity in Turkey?

A: Managing cultural sensitivity in Turkey is central to our process. Our local moderators are trained to understand and manage local customs, social norms, and communication styles. We carefully phrase questions to avoid offense and deliver comfort, particularly when discussing health-related or personal topics. Research design always considers local cultural nuances.

Q: Do you handle both consumer and B2B research in Turkey?

A: Yes, we handle both consumer and B2B research in Turkey. For consumers, this might involve patient journey mapping or health perception studies. For B2B, we frequently interview healthcare professionals, hospital administrators, pharmacists, and biotech industry executives, adapting our recruitment and moderation techniques for each audience.

Q: What deliverables do clients receive at the end of a biotech market research project in Turkey?

A: Clients receive a range of deliverables tailored to their needs. These often include detailed analytical reports, executive summaries, raw data files, and interactive dashboards for quantitative studies. For qualitative projects, we provide full transcripts, thematic analysis, and debrief presentations with key findings and strategic recommendations specific to the Turkish biotech market.

Q: How do you handle quality assurance and back-checks?

A: Quality assurance involves multiple layers. We conduct internal peer reviews of research instruments and analysis plans. During fieldwork, project managers monitor progress and respondent quality. For quantitative data, we implement logic checks and back-checks. Qualitative work includes independent coding verification and review of moderator debriefs.

Q: How do you select moderators or interviewers for Turkey?

A: We select moderators and interviewers for Turkey based on their experience, language proficiency, and subject matter expertise. For biotech research, we prioritize individuals with a background in healthcare, pharmaceuticals, or medical sciences. They undergo specific project training to deliver a deep understanding of the research objectives and cultural context.

When your next research brief involves Turkey, let’s talk through it. Request A Quote or View Case Studies from our work.

Request research

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study